News >

Expert Shares Insight on Precision Medicine Efforts in MCL

Nichole Tucker
Published: Wednesday, Nov 06, 2019

Jia Ruan, MD, PhD

Jia Ruan, MD, PhD
Personalized treatment has been a part of the forefront of mantle cell lymphoma (MCL) treatment, explained Jia Ruan, MD, PhD, particularly with the use of BTK inhibitors, which have resulted in high overall response rates (ORRs), more complete remissions (CRs), and a lower number of adverse events (AEs) in this patient population.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication